메뉴 건너뛰기
Pharmaceutical Science and Technology Today
Volumn 3, Issue 9, 2000, Pages 299-
ED approval for pegylated hepatitis C drug

(1)  Bradley, David a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA2B INTERFERON; MACROGOL; PEGINTRON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;
EID: 0034282132     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1461-5347(00)00290-x     Document Type: Article
Times cited : (2)
References (3)
  • 1
    • 0034060544 scopus 로고    scopus 로고
    • Poly(ethylene glycol) conjugated drugs and prodrugs: A comprehensive review
    • Greenwald, R.B. et al. (2000) Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review. Crit. Rtv. Ther. Drug Carrier Syst. 17, 101-161
    • (2000) Crit. Rtv. Ther. Drug Carrier Syst. , vol.17 , pp. 101-161
    • Greenwald, R.B.1
  • 2
    • 0030992464 scopus 로고    scopus 로고
    • Therapy of hepatitis C
    • Alscher, D.M. andBode. J.C. (1997) Therapy of hepatitis C. Med. Klin. 92, 147-161
    • (1997) Med. Klin. , vol.92 , pp. 147-161
    • Alscher, D.M.1    Bode, J.C.2
  • 3
    • 0034033749 scopus 로고    scopus 로고
    • Combination of ribavirin and interferon-alpha surpasses high doses of interferon-alpha alone in patients with genotype-1b-related chronic hepatitis C
    • Pol. S. et al. (2000) Combination of ribavirin and interferon-alpha surpasses high doses of interferon-alpha alone in patients with genotype-1b-related chronic hepatitis C. Hepatology 31, 1338-1344
    • (2000) Hepatology , vol.31 , pp. 1338-1344
    • Pol, S.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.